<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>33</number>
    <updateDate>2025-05-27T14:15:42Z</updateDate>
    <updateDateIncludingText>2025-05-27T14:15:42Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2023-01-24</introducedDate>
    <congress>118</congress>
    <committees>
      <item>
        <systemCode>ssfi00</systemCode>
        <name>Finance Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2023-01-24T16:58:57Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2023-01-24</actionDate>
        <committees>
          <item>
            <systemCode>ssfi00</systemCode>
            <name>Finance Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Finance.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2023-01-24</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>R000595</bioguideId>
        <fullName>Sen. Rubio, Marco [R-FL]</fullName>
        <firstName>Marco</firstName>
        <lastName>Rubio</lastName>
        <party>R</party>
        <state>FL</state>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <policyArea>
      <name>Taxation</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Aging</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Business expenses</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Business investment and capital</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Cardiovascular and respiratory health</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Community life and organization</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Congressional oversight</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Economic development</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Emergency medical services and trauma care</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Government studies and investigations</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Health technology, devices, supplies</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Income tax credits</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Income tax deductions</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Industrial facilities</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Infectious and parasitic diseases</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Manufacturing</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Minority health</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Public-private cooperation</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Research administration and funding</name>
          <updateDate>2023-03-15T14:15:19Z</updateDate>
        </item>
        <item>
          <name>Research and development</name>
          <updateDate>2023-03-15T14:15:19Z</updateDate>
        </item>
        <item>
          <name>Unemployment</name>
          <updateDate>2023-03-15T14:15:19Z</updateDate>
        </item>
        <item>
          <name>Veterans' medical care</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
        <item>
          <name>Wages and earnings</name>
          <updateDate>2023-03-15T14:15:20Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Taxation</name>
        <updateDate>2023-02-02T13:32:01Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-01-24</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2023-02-02T13:24:47Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;b&gt;Medical Manufacturing, Economic Development, and Sustainability Act of 2023 or the MMEDS Act of 2023&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill provides incentives for relocating medical manufacturing facilities in the United States and for manufacturing medical products (i.e., drugs and devices) in economically distressed zones. Specifically, the bill allows a income tax credit for 40% of the sum of wages paid in a medical product manufacturing economically distressed zone, employee fringe benefit expenses, and depreciation and amortization allowances with respect to qualified medical product manufacturing facility property, and a credit for economically distressed zone products and services acquired by domestic medical product manufacturers..&lt;/p&gt; &lt;p&gt;The bill also directs the Department of Health and Human Services to study the extent to which the health of aging individuals and vulnerable populations have been disproportionately harmed by the COVID-19 (i.e., coronavirus disease 2019) pandemic and prior epidemics and pandemics.&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>MMEDS Act of 2023</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>MMEDS Act of 2023</title>
        <updateDate>2024-07-24T15:24:06Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>MMEDS Act of 2023</title>
        <updateDate>2024-05-24T13:43:00Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Medical Manufacturing, Economic Development, and Sustainability Act of 2023</title>
        <updateDate>2024-05-24T13:43:00Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>A bill to rescue domestic medical product manufacturing activity by providing incentives in economically distressed areas of the United States and its possessions.</title>
        <updateDate>2023-01-28T03:58:53Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2023-01-24T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118s33is/xml/BILLS-118s33is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2023-01-24</actionDate>
      <text>Read twice and referred to the Committee on Finance.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
